Biomarker predicts worsening MS 2 years out, provides treatment window
New research has found that elevation of a biomarker of nerve damage, neurofilament light chain (NfL), predicts the worsening of multiple sclerosis disability up to two years before it occurs. The biomarker provides a timeframe in which interventions c… Continue reading Biomarker predicts worsening MS 2 years out, provides treatment window